MSME (Udyam registered) Ministry of MSME
- Category
- Small (2021-22)
- Udyam number
- UDYAM-TS-20-0029457
Balaji Formulations Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹36.59 Cr
▼ 10% YoY
Net profit · FY 2023
₹8.19 Cr
Net margin 22.4%
EBITDA · FY 2023
₹8.99 Cr
EBITDA margin 24.6%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹2 Cr
Issued & subscribed
Open charges
₹7.3 Cr
Satisfied ₹3.16 Cr
Company age
20 yrs
Est. 2006
Employees · EPFO
25
Provident fund records
About Balaji Formulations Private Limited
Data last updated:
Balaji Formulations Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 September 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24119TG2006PTC051112. Its GSTIN is 36AACCB9454A1ZW (Telangana). The company holds 5 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. It is led by directors including Vongala Venkateswarlu and Vasudev Goud Vangala.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at A – 4 Industrial Estate Moulali, Hyderabad, Telangana, India – 500040.
As per the financials filed for FY 2023, the company reported a revenue of ₹36.59 Cr, a decline of 10% compared to the previous year. For the same year it recorded a net profit of ₹8.19 Cr (net margin 22.4%) and EBITDA of ₹8.99 Cr (EBITDA margin 24.6%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 14% over five years.
The company has about 25 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Balaji Formulations. As per MCA filings, the company has open charges of ₹7.3 Cr and satisfied charges of ₹3.16 Cr on record. Court records list 1 case involving the company, including 1 filed by the company.
Balaji Formulations Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0029457). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website balajiformulations.com.
Company details
CIN U24119TG2006PTC051112
Registration Number 051112
Incorporation Date 12 September 2006
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-20-0029457
CIN history
Balaji Formulations has one previous CIN (Corporate Identification Number): U24119AP2006PTC051112. The current CIN is U24119TG2006PTC051112, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24119TG2006PTC051112 | Current |
| U24119AP2006PTC051112 | Previous |
Recognitions & Rankings of Balaji Formulations
Contact details
Balaji Formulations Private Limited's registered office is in Hyderabad, Telangana. Its website is balajiformulations.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressA – 4 Industrial Estate Moulali, Hyderabad, Telangana, India – 500040
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Balaji Formulations Private Limited, buy the company report.
Comprehensive company report
Balaji Formulations Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Balaji Formulations operates one associated brand: Balaji Formulations. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| It serves as a balaji formulations pvt. | balajiformulations.com |
Business activity
The main business activity of Balaji Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Balaji Formulations Private Limited, buy the company report.
Financials of Balaji Formulations Private Limited
FY 2023 filings availableBalaji Formulations Private Limited reported revenue of ₹36.59 Cr (down 10% YoY) for FY 2023.
Revenue · FY 2023
₹36.59 Cr ▼ 10%
Net profit · FY 2023
₹8.19 Cr margin 22.4%
EBITDA · FY 2023
₹8.99 Cr margin 24.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 10%
3 years · compounded
▲ 11%
5 years · compounded
▲ 14%
EBITDA CAGR growth
1 year
▲ 187%
3 years · compounded
▲ 74%
5 years · compounded
▲ 42%
Revenue fell 10% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 14%. EBITDA rose 187% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.99 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.19 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 24.6% | ||||
| Net Profit Margin | 22.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Balaji Formulations Private Limited, buy the company report.
Board of directors of Balaji Formulations Private Limited
Balaji Formulations has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vongala Venkateswarlu Also directs: Balaji Blue Aggregates LLP | Director | 12 Sep 2006 | 20 Years 1 Months | Current |
| Vasudev Goud Vangala Also directs: Balaji Blue Aggregates LLP | Director | 12 Sep 2006 | 20 Years 1 Months | Current |
| Vijaya Vangala | Director | 12 Sep 2006 | 20 Years 1 Months | Current |
| Vangala Madhavi | Director | 05 Dec 2010 | 15 Years 11 Months | Current |
Peer comparison
Balaji Formulations Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bharat Explosives Limited | ₹36.81 Cr (FY 2025) | -13.0% | Uttar Pradesh, India | |||
| Shukra Pharmaceuticals Limited | ₹36.79 Cr (FY 2025) | -52.0% | Ahmedabad, Gujarat, India | |||
| Gitanjali Chemicals Private Limited | ₹36.72 Cr (FY 2024) | -21.0% | Mumbai, Maharashtra, India | |||
| Anphar Organics Private Limited. | ₹36.7 Cr (FY 2025) | 17.0% | Jammu, Jammu and Kashmir, India | |||
| Balaji Formulations Private Limitedthis company | ₹36.59 Cr (FY 2023) | ₹8.19 Cr | 22.4% | -10.0% | 25 | Hyderabad, Telangana, India |
| Stanex Drugs and Chemicals Private Limited | ₹36.54 Cr (FY 2024) | -47.0% | Hyderabad, Telangana, India | |||
| Vivimed Labs (Alathur) Private Limited | ₹36.32 Cr (FY 2016) | 29.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Balaji Formulations Private Limited, buy the company report.
Shareholding
The shareholding of Balaji Formulations Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Balaji Formulations Private Limited, buy the company report.
Charges & borrowings
Open charges
₹7.3 Cr
Satisfied charges
₹3.16 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 May 2025 | 101124286 | Hdfc Bank Limited | ₹26.13 Lakh | Open | |
| 05 Jun 2024 | 100962361 | Hdfc Bank Limited | ₹12 Lakh | Open | |
| 18 Aug 2023 | 100801212 | Hdfc Bank Limited | ₹36.13 Lakh | Open | |
| 15 Sep 2021 | 100496053 | Hdfc Bank Limited | ₹25.04 Lakh | Open | |
| 27 Mar 2013 | 10420676 | Hdfc Bank Limited | ₹3.15 Cr | Open |
To see the full charge records of Balaji Formulations Private Limited, buy the company report.
Total charge records: 8 View all charges
Legal cases
Balaji Formulations Private Limited has 1 court case on record: 1 filed by Balaji Formulations. All case is disposed.
Total cases
1
Filed by the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Rangareddy, Telangana | Civil suit | Filed by the company against Mayuka Labs Private Limited. | Disposed |
To see the full case history of Balaji Formulations Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Balaji Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Balaji Formulations Private Limited has a workforce of 25 employees on its EPFO records as of Apr 03, 2024, across 1 active EPFO establishment.
Employee count
25
Active EPFO establishments
1
Employee growth
-47.92%
GST
Balaji Formulations has 5 GST registrations: 2 active and 3 cancelled or inactive.
Total GSTINs
5
Active
2
Cancelled / inactive
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AACCB9454A1ZW | Telangana | Active | 01 Jul 2017 |
| 36AACCB9454A4ZT | Telangana | Active | 06 Feb 2018 |
To see the full GST registrations and return filing status of Balaji Formulations Private Limited, buy the company report.
Recent activity
Balaji Formulations Private Limited has 5 board changes on record since 2006: 4 appointments and 1 cessation. The latest: Vangala Bala Narsaiah Goud ceased to be Director on 05 Dec 2010.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.26 Cr with Charge ID 101124286 was registered on 05 May 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.12 Cr with Charge ID 100962361 was registered on 05 Jun 2024.
AGM
Balaji Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.36 Cr with Charge ID 100801212 was registered on 18 Aug 2023.
Filing
Balaji Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
Charges
A charge with Hdfc Bank Limited of Rs. 3.15 Cr registered on 27 Mar 2013 with Charge ID 10420676 was modified on 08 Jan 2022.
Charges
A charge with Hdfc Bank Limited of Rs. 3.15 Cr registered on 19 Feb 2010 with Charge ID 10209888 was modified on 08 Jan 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.25 Cr with Charge ID 100496053 was registered on 15 Sep 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 3.15 Cr with Charge ID 10420676 was registered on 27 Mar 2013.
Charges
A charge registered on 13 Mar 2009 via Charge ID 10147378 with Allahabad Bank was fully satisfied on 31 Dec 2012.
Charges
A charge registered on 05 Feb 2009 via Charge ID 10143938 with Allahabad Bank was fully satisfied on 19 Dec 2012.
Ceased
Vangala Bala Narsaiah Goud ceased to be Director.
8 earlier events are in the company report.
Frequently asked questions
Balaji Formulations is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 September 2006 (20+ years old) and is registered under CIN U24119TG2006PTC051112.
Balaji Formulations has 4 current directors:
- Vongala Venkateswarlu - Director
- Vasudev Goud Vangala - Director
- Vijaya Vangala - Director
- Vangala Madhavi - Director
The latest financial statements of Balaji Formulations on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Balaji Formulations is 36AACCB9454A1ZW, registered in Telangana. The company has 5 GST registrations in all, of which 2 are active and 3 are cancelled or inactive. Other active GSTINs include 36AACCB9454A4ZT (Telangana).
The CIN (Corporate Identification Number) of Balaji Formulations is U24119TG2006PTC051112. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Balaji Formulations has 1 court case on record: 1 filed by the company.
Balaji Formulations was incorporated on 12 September 2006, making it 20+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Balaji Formulations by revenue are Bharat Explosives Limited, Shukra Pharmaceuticals Limited, Gitanjali Chemicals Private Limited, Anphar Organics Private Limited, Stanex Drugs and Chemicals Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Vangala Bala Narsaiah Goud ceased to be Director on 05 Dec 2010. Vangala Madhavi was appointed as Director on 05 Dec 2010. Vasudev Goud Vangala was appointed as Director on 12 Sep 2006. Balaji Formulations has 5 board changes on record in total.
Yes, Balaji Formulations is registered as a small enterprise under Udyam registration (number: UDYAM-TS-20-0029457).
Balaji Formulations can be reached through the website balajiformulations.com. Its registered office is in Hyderabad, Telangana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages